Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-25

Clinical Trial Update: Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Integrated Dual Exercise and Lexiscan PET (IDEALPET) completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lexiscan (regadenoson)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-10-25